HomeAgenda
Accommodation Information
The 4th HTAsiaLink Pre-Conference Short Courses 2015: Provisional Agenda

Venue: Chang Yung-Fa Charity Foundation (CYFCF), Taipei, Taiwan

Date: Tuesday, 12th May 2015
Time Topic/Speaker
08:15-08:30 Registration
08:30-08:40

(Room 1001)
Welcome Remarks

Dr. Churn-Shiouh Gau,
Executive Director,
Center for Drug Evaluation (CDE), Taiwan
08:40-14:00 (Room 1002)
Parallel I:
Systematic Review & Meta-Analysis/

Prof. Olivia Wu,
University of Glasgow, UK;

(Room 1001)
Parallel II:
Economic Evaluation/

Prof. Jeffrey Hoch,
University of Toronto, Canada

Dr. Paul Revill,
University of York, UK

14:15-15:45

(Room 1001)
Plenary I:
Overview of the Use of HTA in Health Policy:
Asian Experiences /

Speakers:

Dr. Jasmine Pwu
Director, NIHTA, Center for Drug Evaluation (CDE), Taiwan

Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea

Dr. Rugayah Bakri
Head of Malaysian Health Technology Assessment Section (MaHTAS), MOH, Malaysia

Dr. Kun Zhao
Director , Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center (CNHDRC), China

Moderator:

Dr. Suwit Wibulpolprasert,
Vice Chair, International Health Policy Program Foundation (IHPF), Health Intervention and Technology Assessment Foundation (HITAF), Ministry of Public Health, Thailand
16:00-17:30 (Room 1002)
Parallel III:
Journal Publications: Writing and Dealing with Journal Editor and Reviewers /
Prof. Mark Sculpher,
University of York, UK

(Room 1001)
Parallel IV:
Meeting Industry:
Communication between HTA Agency and Industry /

Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea

Dr. Jasmine Pwu,
Division of HTA, Center for Drug Evaluation (CDE), Taiwan

Note: 10:00-10:15-Coffee Break
          11:55-13:00-Lunch
          14:00-14:15-Break
          15:45-16:00-Coffee Break

The 4th HTAsiaLink Annual Conference 2015: Provisional Agenda

Theme: Sharing Experiences of HTA for Universal Health Coverage (UHC) in Asia
Venue: Chientan Youth Activity Center, Taipei, Taiwan

Date: 13th-15th May 2015
Day 1: Wednesday, 13th May 2015
Time Topic Speakers
08:30-09:00 Registration
09:00-09:10 Welcome Remarks Dr. Been-Huang Chiang,
Minister, Ministry of Health and Welfare, Taiwan
09:10-09:25 Group Photo
09:25-10:15

(Room 318)
Plenary I: Leaders Forum- Highlights from High-Level Decision Makers on HTA for UHC

Moderator:

Dr. Suwit Wibulpolprasert,
Vice Chair,
International Health Policy Program Foundation (IHPF), Health Intervention and Technology Assessment Foundation (HITAF),
Ministry of Public Health, Thailand

Dr. Ming-Neng Shiu, M.D.,
Vice Minister,, Ministry of Health and Welfare, Taiwan

Dr. Suriya Wongkongkathep,
Deputy Permanent Secretary of Ministry of Public Health, Thailand

Dr. Seulki Kang,
Deputy Director, Division of Healthcare Resources Policy, Ministry of Health and Welfare, Republic of Korea

Mr. Tono Rusiano,
Director, Research and Development, Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan, Indonesia
10:15-10:25 Coffee Break
10:25-10:45

(Room 318)
Plenary II: Policymaker and Academic Collaboration in HTA: UK Experiences and iDSI Activities

Moderator:

Dr. Yot Teerawattananon
Program Leader , Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand

Prof. Mark Sculpher
University of York, UK

Dr. Ryan Li
Adviser, NICE International, UK
10:45-10:55 Q&A
10:55-11:00 Break
11:00-12:09 Parallel Session I

Presentation:
15 min
Q&A: 8 min

(Room 318)
A: Economic Evaluation

Moderator:

Dr. Dewi Indriani
Representative/Focal point for HTA,WHO Indonesia Country Office

Commentators:

Prof. Mark Sculpher
University of York, UK.

Prof. Peter Coyte
University of Toronto, Canada

Presentations:

E1. Cost-Effectiveness Analysis of Endovascular Versus Neurosurgical Treatment for Ruptured and Unruptured Intracranial Aneurysms in Taiwan

E2. Cost-Effectiveness Analysis of Pneumococcal Vaccinations among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Rural China: Based on Individual Level Data

E3. Cost-Utility Analysis of Adjuvant Imatinib in Patients with High Risk of Gastrointestinal Stromal Tumour (GIST) Recurrence in Thailand

(Room 328)
B: Health System Research

Moderator:

Dr. Keng-Ho Pwee
Deputy Director (HTA) ,
Ministry of Health, Singapore

Commentators:

Prof. K. Arnold Chan
College of Medicine, National Taiwan University, Taiwan
Prof. Brendon Kearney
University of Adelaide, Australia

Presentations:

H1. Health Technology Assessment of 6 Transurethral Procedures for Managing Benign Prostatic Hyperplasia: Taiwan Experience on HTA of Single Indication with Various Treatments

H2. Prevalence and Factors Associated with Obesity among Thai Elderly: the 2013 Thai Elderly Health Survey

H3. VNUS® Radiofrequency Ablation (RFA) for Varicose Veins

12:09-13:30 Lunch
13:30-15:25 Parallel Session II
Presentation:
15 min
Q&A: 8 min

(Room 318)
A: Economic Evaluation

Moderator:

Dr. Kun Zhao
Director , Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center (CNHDRC), China

Commentators:

Prof. Olivia Wu
University of Glasgow, UK
Prof. Jeffrey Hoch
University of Toronto, Canada

Presentations:

E4. Budget Impact Analysis of Hepatitis B Standardized Package in China [ONGOING]

E5. Assessment of Health and Economic Impact of Dengue Vaccine in Malaysia

E6. Analyzing Patterns of Healthcare Utilization by Septic Patients in Korea

E7. The Return on Investment of Smoking Cessation Outpatient Clinic Program in Taiwan

E8. Economic Loss due to Inaccessibility of Assistive Devices in Thailand

(Room 328)
B: Health System Research

Moderator:

Prof. Asrul Shafie
School of Pharmaceutical Sciences,
Universiti Sains Malaysia

Commentators:

Prof. Peter Coyte
University of Toronto, Canada

Prof. Wendy Babidge
Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S), Australia

Presentations:

H4. Health Technology Assessment of 21 Selected Robot-Assisted Surgeries: Taiwan Experience on HTA of Single Technology Applied on Varies Indications

H5. Horizon Scanning on a Range of Orthopaedic Technologies: Experience and Outcomes

H6. Rapid Review on Domestically Produced Surgical Robots in China

H7. Developing A Drug Price Reference Index in the Philippines

H8. Evidence-Informed Decision Making for Including Health Promotion and Disease Prevention Interventions in the Universal Health Coverage Benefit Package for Thai Adults: A Review of Effectiveness

15:25-15:40 Coffee Break
15:40-17:35 Parallel Session III
Presentation:
15 min
Q&A: 8 min

(Room 318)
A: Economic Evaluation

Moderator:

Dr. Jasmine Pwu
Director, NIHTA, Center for Drug Evaluation (CDE), Taiwan

Commentators:

Prof. Mark Sculpher
University of York, UK.
Prof. Olivia Wu
University of Glasgow, UK

Presentations:

E9. Introduction of Acupuncture Services at National Traditional Medicine Hospital (2012), Thimphu, Bhutan

E10. Cost Effectiveness Analysis for New Chronic Hepatitis C Drug in China - Evaluation and Evidence-Based Decision Making

E11. Cost-Effectiveness Analysis of Surgical Treatments for Benign Prostatic Hyperplasia

E12. Feasibility and Validity of a Computer-Based Standard Gamble (SG) Prop for Asthma Patients

E13. Economic Evaluation of the Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in the Treatment of Patients with Rheumatoid Arthritis

(Room 328)
B: Health System Research

Moderator:

Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea

Commentators:

Prof. Brendon Kearney
University of Adelaide, Australia
Prof. Jeffrey Hoch
University of Toronto, Canada

Presentations:

H9. Identifying the Priority Methodological Research for Conducting Economic Evaluation in Low- and Middle- Income Countries: Finding the Holy Grail

H10. A Survey Research for the Patients Participation Model of the Health Technology Assessment in Korea

H11. Colorec Bowel Aid with Hai’s Perianal Support (HPS)

H12. Research and Application of Policy Evaluation in Health of China - Based on the Literature Review

H13. Evaluation of Current Reimbursement Policy for Knee Arthroplasty in Taiwan

17:35-20:00 Welcome Party
Day 2:Thursday, 14th May 2015
Time Topic Speakers
08:30-08:50

(Room 318)
Regional Collaboration I:
The Use of HTA Experience in South East Asia, Lessons Learnt from Indonesia

Moderator:

Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea
Dr. Dewi Indriani,
Representative/Focal point for HTA,WHO Indonesia Country Office, Indonesia
08:50-09:10

(Room 318)
Regional Collaboration II:
The Use of HTA for informed Decision-Making in Healthcare Coverage in the Eastern Mediterranean Region

Moderator:

Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea

Dr. Adham R. Ismail,
Eastern Mediterranean Regional-HTA (EMR-HTA)

09:10-09:20 Coffee Break
09:20-10:50

(Room 318)
Plenary III:

Experiences and Difficulties in Developing HTA

Speakers:

Dr. Jasmine Pwu
Director, NIHTA, Center for Drug Evaluation (CDE), Taiwan

Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea

Dr. Rugayah Bakri
Head of Malaysian Health Technology Assessment Section (MaHTAS), MOH, Malaysia

Dr. Kun Zhao
Director , Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center (CNHDRC), China

Moderators:
Prof. Vicharn Panich, M.D.,
Senior Advisor, Health Intervention and Technology Assessment Foundation (HITAF), Thailand
Dr. Ryan Li,
Adviser, NICE International, UK
10:50-11:15 Q&A
11:15-12:05 Parallel session IV
 

A: Economic Evaluation

Moderator:

Dr. Rugayah Bakri
Head of Malaysian Health Technology Assessment Section (MaHTAS), MOH, Malaysia

Commentators:

Prof. Olivia Wu
University of Glasgow, UK
Prof. Peter Coyte
University of Toronto, Canada

Presentations:

E14. Health-State Utilities in Measuring Health-Related Quality of Life among Patients with Rheumatoid Arthritis in Taiwan

E15. A Policy Model of Alcohol-Related Harms for Predicting Life Years and Quality-Adjusted Life Years

B: Health System Research

Moderator:

Prof. Asrul Shafie
School of Pharmaceutical Sciences,
Universiti Sains Malaysia

Commentators:

Prof. K. Arnold Chan
College of Medicine, National Taiwan University, Taiwan
Prof. Wendy Babidge
Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S), Australia

Presentations:

H14. The Journey to HTA in Low- and Middle-Income Countries: Conducive Factors and Barriers to HTA Development

H15. Review of Maternal and Child Health Voucher Scheme: Review of the First Six Months

12:05-13:30 Lunch
13:30-15:25 Parallel session V
Presentation:
15 min
Q&A: 8 min

(Room 318)
A: Economic Evaluation

Moderator:

Prof. Ming-Chin Yang
Institute of Health Policy and Management, National Taiwan University, Taiwan

Commentators:

Prof. Mark Sculpher
University of York, UK.

Prof. Jeffrey Hoch
University of Toronto, Canada

Presentations:

E16. The Economic Evaluation about the Cost Estimation of the Clinical Pathway in China

E17. Cost-Effectiveness Analysis of Direct Acting Antiviral Agents in Previous Treatment Failure HCV Genotype 1 Patients in Taiwan

E18. Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines

E19. Does the WHO Package Of Essential Non-Communicable Disease (PEN) Interventions Represent Good Value for Money in Resource-Limited Settings

E20. Cost-Effectiveness Analysis of Robot Assisted Radical Prostatectomy Compared with Open and Laparoscopic Surgery

(Room 328)
B: Health System Research

Moderator:

Dr. Yot Teerawattananon
Program Leader , Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand

Commentators:

Prof. Brendon Kearney
University of Adelaide, Australia
Prof. Wendy Babidge
Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S), Australia

Presentations:

H16. Platelet Rich Plasma: A Case Study for the Identification of Disinvestment Opportunities in the Public Health System Using Horizon Scanning

H17. Assessment of the Twelfth Five-Year (2011-2015) Development Plan of Health and Family Planning indicator system

H18. Development and Validation of Breast Cancer Risk Prediction Model in Thai Women

H19. Association Among Calendar Packaging and Medication Adherence: Findings from a Focus Group Discussion among Hypertensive Patients in Penang, Malaysia

H20. Priority Setting for Health Technology Assessment Research at NECA

15:25-15:40 Coffee Break
15:40-17:35 Parallel session VI
Presentation:
15 min
Q&A: 8 min

(Room 318)
A: Economic Evaluation

Moderator:

Prof. K. Arnold Chan
College of Medicine, National Taiwan University, Taiwan

Commentators:

Prof. Peter Coyte
University of Toronto, Canada

Prof. Jeffrey Hoch
University of Toronto, Canada

Presentations:

E21. Evaluation of the Pricing Reform in Eastern China

E22. Effectiveness of Interferon-Free Compared with Interferon-Based Regimens for Treatment Naïve and Null Responders HCV Genotype 1 Infection: A Systematic Review and Meta-Analysis

E23. Comparative Effectiveness of Clipping and Coiling Treatments for Intracranial Aneurysm in Taiwan

E24. Effectiveness of Bevacizumab and Ranibizumab in the Real World: An Observational Study in Patients with Retinal Diseases in Thailand

E25. Cost-Analysis of 21 Robot-Assisted Surgeries: A Pragmatic Approach for Supporting Reimbursement Decision in Taiwan

(Room 328)
B: Health System Research

Moderator:

Dr. Takashi Fukuda
Chief Senior Researcher , National Institute of Public Health (NIPH), Japan

Commentators:

Prof. Brendon Kearney
University of Adelaide, Australia
Prof. Olivia Wu
University of Glasgow, UK

Presentations:

H21. Comparative Effectiveness of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

H22. T.SPOT.TB Assay – An Update

H23. Effectiveness of the Risk Assessment Tools for Cardiovascular Disease Prevention in Adults in Thailand: A Comparison Between WHO/ISH Prediction Chart and Thai ASCVD Score

H24. Use of Segmented Regression Analysis in Evaluation of China Rural Integrated Care Pathway

H25. Development of Health Promotion Program for Informal Sector in Thailand under Universal Health Coverage Scheme

Day3: Friday, 15th May 2015
Time Topic Speakers
09:00-09:15

(Room 318)
Collaborative Study I:
Country’s Mapping Report

Moderator:

Dr. Jasmine Pwu
Director, NIHTA, Center for Drug Evaluation (CDE), Taiwan

Mr. Rex Chih-Chung Huang
Assistant Researcher,
NIHTA, Center for Drug Evaluation (CDE), Taiwan

09:15-09:25 Q&A
09:25-09:40

(Room 318)
Collaborative Study II:
QoL Study Report

Moderator:

Dr. Jasmine Pwu
Director, NIHTA, Center for Drug Evaluation (CDE), Taiwan
Dr. Jeonghoon Ahn
Executive Director of the Office of Research Planning , National Evidence-based healthcare Collaborating Agency (NECA), Korea
09:40-09:50 Q&A
09:50-10:30

(Room 318)
Plenary IV: Impact of HTA
Agency’s Contributions

Moderator:

Prof. Mark Sculpher
University of York, UK

Ms. Eleanor Grieve
University of Glasgow, UK

Dr. Paul Revill
University of York, UK
10:30-10:40 Q&A
10:40-10:55 Coffee Break
10:55-11:25

(Room 318)
Closing Remarks

Moderator:

Dr. Jasmine Pwu
Director, NIHTA, Center for Drug Evaluation (CDE),Taiwan
President, 2015 HTAsiaLink
11:25-11:35 (Room 318)
Award Ceremony
11:35-11:55 (Room 318)
Closing Remarks
(2016 HTAsiaLink President)
11:55-13:00 Lunch
13:00-15:00 (Room 314)
Full-House Meeting (HTAsiaLink Members)
(1) PMAC 2016
(2) HTAsiaLink Governance and Procedure
15:00-15:30 (Room 314)
HTAsiaLink Board Meeting